Search database
Filter
104
Text search: Moderna vaccine
Featured
Language
Document type
Fact sheets
30
Studies & Reports
27
Guidelines
22
Manuals
6
Resource Platforms
5
Training Material
4
Online Courses
3
Infographics
2
Strategic & Response Plan
2
No document type
2
Videos
1
Countries / Regions
Germany
9
Ukraine
5
Argentina
4
Middle East and North Africa
4
Paraguay
4
China
3
Brazil
3
Russia
3
Global
3
Colombia
2
Ecuador
2
Latin America and the Carribbean
2
Guinea-Bissau
1
Ghana
1
Haiti
1
Philippines
1
Kenya
1
South Africa
1
Mozambique
1
Angola
1
Chile
1
East and Southern Africa
1
West and Central Africa
1
South–East Asia Region
1
Western and Central Europe
1
Africa
1
Eastern Europe
1
United Kingdom
1
Authors & Publishers
World Health Organization WHO
18
World Health Organization WHO, Regional Office of Europe
8
Ministerio de Salud Argentina
4
Robert-Koch-Institut RKI
4
Amnesty International
3
Centre d’études stratégiques de l’Afrique
3
Dirección de Control de Enfermedades Inmunoprevenibles
3
Open WHO
3
World Health Organisation (WHO)
3
Mauder, S.
2
Ministerio de Salud Pública de Ecuador
2
Ministerio de Salud Pública, Paraguay
2
OPAS
2
Pan American Health Organisation PAHO
2
Partnership for Evidence-Based Response to COVID-19 (PERC)
2
Robert-Koch-Institut RKI, Deutsches Grünes Kreuz
2
Rüppel, T.
2
United States Conference of Catholic Bishops
2
A. García-Prado, J.P. Sarmiento, et al.
1
Abu Mouch et al.
1
Accreditation Counci for Continuing Medical Education
1
Action against AIDS
1
Africa CDC Centres for Disease Control and Prevention
1
African Union
1
and J. Rüppel
1
and P. Reijer
1
Arrieta, A.
1
Asean Briefing
1
Bracho C., Martinez C. et al.
1
British Society for Immunology
1
C. Clift
1
CDC
1
Cerda A. A., Garcia L. Y.
1
Chairmen of the Committee on Doctrine and the Committee on Pro-Life Activities
1
Coalition for Epidemic Preparedness Innovations (CEPI)
1
COVIMO
1
Deutsches Grünes Kreuz e. V., Marburg, Robert Koch-Institut RKI
1
E. Ross
1
et al.
1
European Centre for Disease Prevention and Control ECDC
1
European Medicines Agency EMA
1
Florida International University
1
Food and Drug Administration
1
Gavi, the Vaccine Alliance
1
Greinacher, A., et al.
1
Harding-Zentrum für Risikokompetenz
1
Health Cluster, WHO
1
Infection Prevention and Control UHL, WHO Headquarters
1
International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health
1
Internews
1
Kamradt, T., and B.S. Kamps
1
Kamradt, T., B.S. Kamps J. García-Rosales Delgado
1
la DiCEI del Ministerio de Salud de la Nación en conjunto con la Comisión Nacional de Seguridad en Vacunas (CoNaSeVa)
1
Limaya, R.J.
1
MEDBOX Team
1
Medical Mission Institute
1
Ministerio de Salud y Protección Social Bogotá, Colombia
1
Ministerio de Salud, Colombia
1
Msomi, N.
1
National Department of Health, South Africa
1
News-FR-24
1
NICE
1
Organisation Mondiale de la Santé OMS
1
Organisation mondiale de la Santé OMS
1
Organización Mundial de la Salud OMS
1
Organización Mundial de Saude and OPAS
1
Organização Mundial da Saúde (OMS)
1
Pan American Health Organisation PAHO, et al.
1
R. Lessells, K. Mlisana and T. de Oliveira
1
Rahman-Shepherd, A.
1
Robert-Koch-Institut
1
Robert-Koch-Instiut RKI
1
RüppelT.
1
SickKids
1
Sociedad Paraguaya de Pediatria
1
The Chatham House
1
The Telegraph
1
UK Health Security Agency
1
UNICEF
1
Vygen-Bonnet S, Koch J, Bogdan C, et al.
1
World Bank
1
World Health Organization WHO and World Intellectual Property Organization
1
World Health Organization WHO, Regional Office of Africa
1
World Health Organization WHO, SAGE
1
WTO, WHO, WIPO
1
Publication Years
Category
Countries
43
Clinical Guidelines
3
Key Resources
3
Annual Report MEDBOX
1
Public Health
1
Pharmacy & Technologies
1
Toolboxes
COVID-19
89
Refugee
3
Conflict
2
Health Financing Toolbox
2
Rapid Response
1
TB
1
Pharmacy
1

Vaccine Hesitancy and COVID-19: Considerations for Communication

Limaya, R.J. International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health (2021) C1
This presentation presents the issues we confront in deciding how to communicate to the public that COVID-19 vaccine recommendations reflect the state of scientific knowledge.
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i ... more
10 February 2021. Draft
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized ... more
It will be updated continuously. Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations. Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in ... more
Many critical questions remain about the effectiveness of COVID-19 vaccines in real-world settings. These questions can only be answered in post-introduction vaccine effectiveness studies.This guidance document outlines an approach to leverage exist ... more
first issued 18 August 2022
Overview 16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored ... more
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si ... more
5 April 2022, Addendum. This policy brief confirms WHO guidance and policy on injection safety in the context of the extraordinary increase in global injections resulting from COVID-19 immunization campaigns. It also calls attention to information on specialized syringes for COVID-19 vaccines and br ... more
COVID-19 vaccine hesitancy is currently one of the main obstacles to worldwide herd immunity and socioeconomic recovery. Because vaccine coverage can vary between and within countries, it is importa ... more
Child and adolescent vaccine safety report This report on the safety of COVID-19 vaccination in children and adolescents in Argentina includes data from the start of the adolescent campaign in Argentina, includes data reported since the start of t ... more
Vaccinator's Manual. Pfizer-BioNTech Comirnaty Vaccine
Comirnaty® 10 μg und 30 μg von BioNTech / Pfizer und Spikevax® von Moderna Stand 21. Dezember 2021
Vaccinator's Manual. CONVIDECIA Vaccine
Introduction: Considering the global prevalence of coronavirus disease 2019 (COVID-19), a vaccine is being developed to control the disease as a complementary solution to hygiene measures—and better, in social terms, than social distancing. Given ... more